Evidence map›Paper›PMID 34153023›Full record

ArticleThe American journal of case reports2021

Iris Melanocytoma in a Child: Clinical and Histopathological Findings.

Abdulkarim Al-Kharashi, Wael A Alsakran, Abdulaziz A Alshamrani, Abdulrahman AlZaid, Azza M Y Maktabi, Yahya A Alzahrani

Open access · greenAbstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Abdulkarim Al-KharashiKing Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Wael A AlsakranKing Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Abdulaziz A AlshamraniKing Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Abdulrahman AlZaidKing Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Azza M Y MaktabiKing Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Yahya A AlzahraniKing Fahad Medical City, Riyadh, Saudi Arabia.
King Khaled Eye Specialist Hospital · SAKing Fahd Medical City · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Melanocytoma is rare and can affect any part of the uveal tract. In rare cases, iris melanocytoma shows signs of growth, with extrascleral extension that mimics melanoma. This phenomenon makes clinical differentiation between the 2 pathologies particularly challenging. CASE REPORT A 3-year-old boy presented with recurrent ocular inflammation. Examination revealed a large, solid, homogenous mass in the inferior quadrants of the iris, with secondary localized corneal edema. The lesion did not extend to the ciliary body and fundus examination showed no lesions in the posterior segment, including the head of the optic nerve. The patient underwent a sectoral iridocyclectomy and excisional biopsy of the lesion in the iris. Histopathology of the lesion confirmed the diagnosis of iris melanocytoma. CONCLUSIONS The differential diagnosis for a mass in the iris is broad, ranging from benign cysts to melanoma, which is a life-threatening ocular condition. An iris melanocytoma always should be considered in the differential of these masses, despite their exceedingly low incidence. Although iris melanocytoma mainly manifests in patients who are middle-aged or older, it should be suspected in young children, as underscored by the present report.

Indexed as

Nevus, PigmentedSkin NeoplasmsUveal NeoplasmsChild, PreschoolCiliary BodyHumansIrisMale

Identifiers

PMID34153023
PMCPMC8235677
OpenAlexW3163979248

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.